![CME Programme CSHK mw_menu_data_5564_56eb2b174e5e3.jpg](https://cshk.org/site/CSHK/upload/mw_menu_data/file/mw_menu_data_5564_56eb2b174e5e3.jpg)
CME Programme
-
Non-Regular Activities
Heading in the Right Direction: Optimizing clinical outcomes of ovarian cancer patientsDate: 14/07/2022 Enquiries: AstraZeneca (Hong Kong) CME Points Awarded: 1 point
CME Programme
Date: | 14/07/2022 |
Enquiries: | AstraZeneca (Hong Kong) |
CME Points Awarded: | 1 point |